KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America (Class 5)
#4092260
Application Number:4092260
Status:
Unknown
Class:5
Applicant: CORCEPT THERAPEUTICS INCORPORATED
Filing Date:Tue, 19 Feb 2019
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 4092260 |
| Nature/Scope of business | Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders |
| Publication | In Journal No. 2137 |
| Status | Unknown |
| Applicant: | CORCEPT THERAPEUTICS INCORPORATED |
| Applicant Address | 149 Commonwealth Drive, Menlo Park, California 94025, United States of America a Delaware corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
Who is the owner of trademark KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America? ▾
The trademark application number 4092260 is owned by CORCEPT THERAPEUTICS INCORPORATED.
Which class does trademark KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America belong to? ▾
Trademark application number 4092260 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4092260? ▾
The trademark agent associated with application number 4092260 is REMFRY & SAGAR.
Was trademark KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America published in the journal? ▾
Yes, trademark application number 4092260 was published in Journal No. 2137.
What is trademark KORFINITIPriority claimed from 28/08/2018; Application No. : 88/096081 ;United States of America? ▾
Trademark application number 4092260 relates to "Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified